Loading financial statements…
Import this data to Google Sheets with:
=jivedata("KWR","financials")Full statements spill as a table. For one cell: =jivedata("KWR","Revenue") or =jivedata("KWR","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
KWR • CIK 0000081362
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax | $1,953,313 | $1,839,686 | $1,888,634 | $1,975,349 |
| Cost of Goods and Services Sold | $1,247,669 | $1,153,656 | $1,209,262 | $1,263,021 |
| Gross Profit | $705,644 | $686,030 | $679,372 | $712,328 |
| Selling, General and Administrative Expense | $483,561 | $484,794 | $502,416 | $533,020 |
| Asset Impairment Charges | $0 | $0 | $88,840 | $0 |
| Restructuring Charges | $7,588 | $6,530 | $35,130 | $27,244 |
| Operating Income (Loss) | $214,495 | $194,706 | $52,986 | $152,064 |
| Nonoperating Income (Expense) | $-10,672 | $1,354 | $-1,909 | $-164 |
| InterestExpenseNonoperating | — | $41,002 | $44,048 | $41,476 |
| Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | $153,124 | $155,058 | $7,029 | $110,424 |
| Income Tax Expense (Benefit) | $55,585 | $49,300 | $24,607 | $29,910 |
| Income (Loss) from Equity Method Investments | $15,333 | $10,971 | $15,177 | $17,286 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $112,872 | $116,729 | $-2,401 | $97,800 |
| Net Income (Loss) Attributable to Noncontrolling Interest | $124 | $85 | $87 | $126 |
| Net Income (Loss) Attributable to Parent | $112,748 | $116,644 | $-2,488 | $97,674 |
| Undistributed Earnings (Loss) Allocated to Participating Securities, Basic | $555 | $375 | $-20 | $224 |
| Net Income (Loss) Available to Common Stockholders, Basic | $112,193 | $116,269 | $-2,468 | $97,450 |
| Weighted Average Number of Shares Outstanding, Basic | 17,892,461 | 17,850,462 | 17,472,907 | 17,084,758 |
| Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted | $554 | $375 | $-20 | $223 |
| Net Income (Loss) Available to Common Stockholders, Diluted | $112,194 | $116,269 | $-2,468 | $97,451 |
| Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | 22,348 | 19,605 | 0 | 56,890 |
| Weighted Average Number of Shares Outstanding, Diluted | 17,914,809 | 17,870,067 | 17,472,907 | 17,141,648 |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 10,621 | 32,353 | 79,144 | 50,974 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $194,527 | $188,880 | $179,829 | $155,093 |
| Accounts Receivable, after Allowance for Credit Loss, Current | $444,950 | $400,126 | $417,157 | $463,603 |
| Property, Plant and Equipment, Net | $207,811 | $229,532 | $313,423 | $314,596 |
| Inventory, Net | $233,857 | $227,472 | $265,776 | $265,776 |
| Operating Lease, Right-of-Use Asset | $38,614 | $34,120 | $38,737 | $53,650 |
| Prepaid Expense and Other Assets, Current | $54,555 | $59,939 | $58,428 | $68,242 |
| Goodwill | $512,518 | $518,894 | $501,720 | $503,721 |
| Assets, Current | $927,889 | $876,417 | $921,190 | $991,048 |
| Intangible Assets, Net (Excluding Goodwill) | $896,721 | $827,098 | $873,540 | $829,479 |
| Equity Method Investments | $101,151 | $98,012 | $106,915 | $105,906 |
| Deferred Income Tax Assets, Net | $10,737 | $9,216 | $12,128 | $12,737 |
| Other Assets, Noncurrent | $18,770 | $17,360 | $30,283 | $39,979 |
| Assets | $2,714,211 | $2,610,649 | $2,797,936 | $2,851,116 |
| Long-term Debt, Excluding Current Maturities | $730,623 | $669,614 | $834,901 | $857,790 |
| Operating Lease, Liability, Noncurrent | $22,937 | $20,028 | $22,759 | $37,628 |
| Deferred Income Tax Liabilities, Net | $146,957 | $138,828 | $140,814 | $131,314 |
| Liability, Defined Benefit Plan, Noncurrent | $29,457 | $23,783 | $20,615 | $20,159 |
| Other Liabilities, Noncurrent | $31,805 | $24,445 | $22,192 | $20,229 |
| Liabilities | $1,329,289 | $1,256,466 | $1,421,437 | $1,470,517 |
| Debt, Current | $23,444 | $37,554 | $35,657 | $15,654 |
| Accounts Payable, Current | $184,813 | $198,137 | $198,929 | $234,319 |
| Dividends Payable, Current | $8,186 | $8,572 | $8,804 | $8,744 |
| Accrued Salaries, Current | $55,194 | $50,212 | $41,192 | $41,280 |
| Restructuring Reserve, Current | $3,350 | $2,297 | $8,351 | $8,807 |
| Liability, Defined Benefit Plan, Current | $2,208 | $2,328 | $2,126 | $2,120 |
| Other Liabilities, Current | $90,315 | $80,668 | $85,097 | $92,473 |
| Liabilities, Current | $367,510 | $379,768 | $380,156 | $403,397 |
| Common Stock, Value, Issued | $17,992 | $17,674 | $17,332 | $17,213 |
| Additional Paid in Capital, Common Stock | $940,101 | $903,781 | $874,826 | $855,896 |
| Retained Earnings (Accumulated Deficit) | $550,641 | $633,731 | $596,616 | $625,554 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $-124,415 | $-201,619 | $-115,661 | $-121,488 |
| Stockholders' Equity Attributable to Parent | $1,384,319 | $1,353,567 | $1,373,113 | $1,377,175 |
| Stockholders' Equity Attributable to Noncontrolling Interest | $603 | $616 | $3,386 | $3,424 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $1,384,922 | $1,354,183 | $1,376,499 | $1,380,599 |
| Common Stock, Shares Authorized | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 |
| Common Stock, Shares, Issued | 17,991,988 | 17,673,607 | 17,331,779 | 17,212,963 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $112,872 | $116,729 | $-2,401 | $97,800 |
| Net Cash Provided by (Used in) Operating Activities | $279,020 | $204,578 | $136,453 | $131,173 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | $771 | $-11,141 | $6,782 | $-1,631 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $13,564 | $-5,647 | $-9,051 | $-46,825 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $194,527 | $188,880 | $179,829 | $163,334 |
| Results of Operations, Depreciation, Depletion, Amortization and Accretion | $81,987 | $84,119 | $93,453 | $100,186 |
| Payments to Acquire Property, Plant, and Equipment | $38,800 | $41,794 | $55,856 | $56,585 |
| Income (Loss) from Equity Method Investments, Net of Dividends or Distributions | $11,149 | $2,733 | $6,648 | $10,200 |
| Payments to Acquire Businesses, Net of Cash Acquired | $0 | $39,302 | $164,209 | $131 |
| Deferred Income Tax Expense (Benefit) | $-11,442 | $-10,033 | $-30,428 | $-26,524 |
| Proceeds from Sale of Property, Plant, and Equipment | $11,179 | $4,676 | $2,995 | $45 |
| Restructuring Charges | $7,588 | $6,530 | $35,130 | $27,244 |
| Payments for (Proceeds from) Other Investing Activities | — | — | $-2,951 | $-4,503 |
| Share-based Payment Arrangement, Noncash Expense | $14,605 | $14,991 | $13,611 | $13,596 |
| Net Cash Provided by (Used in) Investing Activities | $-27,621 | $-76,420 | $-214,119 | $-52,168 |
| Gain (Loss) on Disposition of Property Plant Equipment | $1,307 | $810 | $2,204 | $-25 |
| Asset Impairment Charges | $0 | $0 | $88,840 | $0 |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit) | $-2,079 | $-4,460 | $-4,132 | $-4,132 |
| Other Operating Activities, Cash Flow Statement | — | — | $-5,564 | $-2,213 |
| Increase (Decrease) in Accounts Receivable | $-32,169 | $-24,975 | $-24,232 | $26,418 |
| Repayments of Long-term Debt | $38,932 | $57,221 | $34,722 | $647,202 |
| Increase (Decrease) in Inventories | $-49,751 | $3,244 | $12,239 | $41,098 |
| Increase (Decrease) in Prepaid Expense and Other Assets | $21 | $6,242 | $-3,069 | $3,438 |
| Proceeds from (Repayments of) Other Debt | $-506 | $1,441 | $-386 | $-285 |
| Increase (Decrease) in Restructuring Reserve | $-9,786 | $-7,595 | $-26,598 | $-21,992 |
| Payments of Ordinary Dividends, Common Stock | $31,650 | $33,170 | $34,393 | $34,874 |
| Increase (Decrease) in Accounts Payable and Accrued Liabilities | $5,937 | $-8,637 | $-30,268 | $35,759 |
| Payments for Repurchase of Common Stock | — | $49,247 | $41,521 | $33,009 |
| Increase (Decrease) in Income Taxes Payable | $3,415 | $-2,920 | $-1,714 | $-1,714 |
| Proceeds from Issuance or Sale of Equity | $-2,749 | $-2,383 | $-1,387 | $-1,841 |
| Net Cash Provided by (Used in) Financing Activities | $-238,606 | $-122,664 | $61,833 | $-124,199 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $54,892 | $44,536 | $42,788 | $42,788 |